About KOMZIFTI™ KOMZIFTI (ziftomenib) is an oral menin inhibitor approved for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible NPM1 mutation ...
Doctors often treat high blood pressure with medicine. One common drug is chlorthalidone. It helps lower blood pressure, ...
A major study from Columbia University has given doctors and patients new insights into treating high blood pressure. Over a span of 17 years, researchers studied more than 730,000 people who were ...
Artificial intelligence-enabled electrocardiography from scientific research to clinical application
Recent advancements in artificial intelligence (AI) have revolutionized the application of electrocardiography (ECG) in ...
HYPOKALEMIC alkalosis has been variously reported as common 2,3 and rare 4 in Cushing's syndrome. Plotz, Knowlton and Ragan 5 reported 4 cases of severe hypokalemia in 31 patients with this disease.
Bristol Myers Squibb today announced the presentation of more than 95 data disclosures, including 27 oral presentations, across company-sponsored studies and external collaborations at the 67th ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback